In summary, members of the Hsp70/DnaK family are involved in the carcinogenic mechanisms in BC (Figure 2), and they can therefore be considered potential targets for treating BC via negative chaperonotherapy, namely the inhibition/blocking of the pathogenic chaperones. The gene discussed is HSPA1A; the disease is breast cancer.